Article Per Year (5 Year)
p-Index From 2020 - 2025
1.829
P-Index
This Author published in this journals
All Journal Jurnal Mandala Pharmacon Indonesia Jurnal Inovasi Farmasi Indonesia Journal of Herbal, Clinical and Pharmaceutical Science (HERCLIPS) JOURNAL OF COMMUNITY ENGAGEMENT AND EMPOWERMENT Jurnal Sintesis: Penelitian Sains, Terapan dan Analisisnya Journal for Quality in Public Health Jurnal Pharma Bhakta
Admaja, Wika
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Decision Sciences, Operations Research & Management Environmental Science Health Professions Immunology & microbiology Library & Information Science Materials Science & Nanotechnology Mathematics Medicine & Pharmacology Nursing Physics Public Health Veterinary Other

Published : 10 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Jurnal Mandala Pharmacon Indonesia

 1 
Suitability Of Real Cost To Tariff Of INA-Cbgs Of Hypertensive Patients At X General Hospital Restyana, Anggi; Admaja, Wika
Jurnal Mandala Pharmacon Indonesia Vol. 10 No. 1 (2024): Jurnal Mandala Pharmacon Indonesia
Publisher : Program Studi Farmasi Universitas Mandala Waluya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35311/jmpi.v10i1.450

Abstract

Hypertension referred to as the "silent killer". Hypertension is a non-communicable disease that one of the leading causes death in the world. Increasing prevalence of hypertension based on measurements Indonesia in the population aged (18 years by 34.11% with the highest hypertension sufferers in South Kalimantan at 44.13% and the lowest prevalence of hypertension in Papua at 22.22%. In Indonesia, health costs keep increasing due to degenerative diseases. This study aims to determine the Real Cost of hypertensive patients and to determine the difference in Real Cost to the INA CBGs tariff of hypertensive inpatients at General Hospital X Kediri regarding the class of treatment, severity and length of treatment. This study was a descriptive quantitative research using a cross sectional design with retrospective data. The results of the study of the real cost of hospital of hypertensive patients with or without comorbidities at Public Hospital X Kediri was Rp.408,473,500. Meanwhile, the INA CBGs tariff was Rp.211,709,100 so that the difference obtained was negative Rp.196,764,400. The cost consists of class 1 treatment (13 patients) was Rp. (-32,884,800), class 2 (16 patients) was Rp. (-25,262,600) and class 3 (79 patients) was Rp. (-138,617,000). The difference in severity was mild severity (81 patients) of Rp. (-144,856,800), moderate severity (20 patients) of Rp. (-39,647,000) and severe severity (7 patients) of Rp. (-12,260,600). The difference in length of hospital stay 0-5 days (66 patients) was Rp.(-85,504,600), length of hospital stay 6-10 days (41 patients) was Rp.(-107,463,600) and length of hospital stay (10 days (1 patient) was Rp.(-3,796,200). The real cost of hospital was greater than the INA CBGs tariff, thus causing a negative cost difference that can make financial loss to the hospitals.
Cost Effectiveness Analysis of Antibiotics in Appendicitis Surgery Patients at Kediri City Hospital Restyana, Anggi; Admaja, Wika; Wibisono, Adi
Jurnal Mandala Pharmacon Indonesia Vol. 10 No. 2 (2024): Jurnal Mandala Pharmacon Indonesia
Publisher : Program Studi Farmasi Universitas Mandala Waluya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35311/jmpi.v10i2.617

Abstract

Pre and post-appendicitis guideline therapy include broad-spectrum antibiotics before surgery, appendectomy (laparoscopic or open), and follow-up antibiotics post-surgery in complicated cases of appendicitis. The incidence of appendicitis is estimated to be around 100 cases per 100,000 people per year, with a consistent incidence rate in Western countries and an increasing trend in developing regions. In Indonesia, there are 24.9 cases of acute appendicitis per 10,000 people. The use of antibiotics in appendicitis surgery has been widely used. In most studies, it is known that the most widely used types of prophylactic antibiotics are second or third generation cephalosporins or a combination of metronidazole, either given as a single dose, two or three doses. However, there has been no research on direct comparisons between antibiotics. Most studies have not found significant differences in the incidence of SSI. In Indonesia, health financing uses the National Health Insurance system which requires cost-effective therapy. This study aims to determine the cost-effectiveness between the use of cefoperazone-metronidazole and ceftriaxone. The perspective in this study uses the perspective of health care facilities. Costs are observed in two classes of care and effectiveness is measured through the incidence of Surgical Wound Infection. The results of cefoperazone-metronidazole antibiotic therapy compared to ceftriaxone in insurance patients obtained an ICER value of Rp 94,380.68,-. So the use of cefoperazone-metronidazole antibiotics will incur additional costs of Rp 94,380.68,- per increase in therapy outcomes. While in the analysis of the cost-effectiveness of cefoperazone-metronidazole antibiotic therapy compared to ceftriaxone in non-insured patients, the average cost was lower with higher effectiveness with cefoperazone-metronidazole antibiotic therapy than using therapy with ceftriaxone antibiotics. Thus, cefoperazone-metronidazole antibiotics can be considered as the main choice in non-insured patient therapy. In this study, no relationship was found between demographic factors, type of appendicitis and class of care on the incidence of surgical wound infections.
Co-Authors Amelia, Faresa Esti Ambar Widyaningrum Farida, Umul Hidayatunnisa, Shafira Indah Sri Hartini Khusnul Khulukia, Widya Kusumaratni, Dyah Ayu Marhenta, Yogi Bhakti Nunki Rosa Fitria Prasetyo, Eko Yudha Restyana, Anggi Salsabila, Amaliyah Seran, Krisogonus Ephrino Ubanayo, Kristian Wahyuni, Kumala Sari Poespita Dewi Walujo, Djembor Sugeng Wibisono, Adi